#United States #New York #Class Action #Levi & Korsinsky #LifeMD

LifeMD, Inc. Class Action Lawsuit: What Investors Need to Know

In a recent announcement, Levi & Korsinsky, LLP has informed shareholders of LifeMD, Inc. (NASDAQ: LFMD) regarding a significant class action securities lawsuit. This crucial legal action focuses on the financial losses endured by investors within a specific timeframe, raising concerns about potential securities fraud.

Background of the Lawsuit

The class action lawsuit encompasses investors who suffered losses attributable to alleged misconduct by LifeMD's executives and board members. Specifically, it claims that LifeMD's management made several misleading statements and failed to disclose vital information that significantly inflated the company’s market standing.

The lawsuit covers the period from May 7, 2025, to August 5, 2025. During this time frame, the management purportedly overstated LifeMD's competitive position and inaccurately raised predictions regarding their 2025 financial guidance. This was reportedly done without adequately considering the surging customer acquisition costs in their RexMD segment and related to obesity treatment medications such as Wegovy and Zepbound.

These misrepresentations led to misleading statements about the overall operations and future prospects of LifeMD, causing tremendous upheaval in its stock value and significant financial losses for unwary investors.

What Investors Should Do

Affected investors have a clear course of action: you must act before October 25, 2025, if you wish to be designated as a lead plaintiff in this class action. It's essential to understand that you do not need to hold this title to participate in any potential recovery. Therefore, it is imperative for those who experienced losses with LifeMD to evaluate their eligibility for participation in the lawsuit promptly.

For more information, interested parties can visit the law firm’s dedicated webpage here. Additionally, contacting Joseph E. Levi, Esq. at Levi & Korsinsky will provide further clarity. Investors can reach him via email at [email protected] or call (212) 363-7500 for assistance.

No Financial Burden for Participants

One of the most encouraging aspects of this lawsuit is that shareholders participating in this class action can do so without any out-of-pocket costs or fees. There's no financial burden or obligation involved in joining the lawsuit, making it an accessible option for those recovering from losses.

Why Choose Levi & Korsinsky?

Levi & Korsinsky has established a formidable reputation over the past two decades, securing hundreds of millions of dollars for investors from across various sectors. The firm boasts extensive expertise in handling complex securities litigation and has a dedicated team of over 70 professionals focused on client service. Their consistent ranking in ISS Securities Class Action Services' Top 50 Report reinforces their status as one of the top securities litigation firms in the U.S.

Final Thoughts

As the LifeMD, Inc. class action lawsuit progresses, it is crucial for affected investors to stay informed and to take necessary action to ensure they do not miss the opportunity for recovery. Gathering pertinent documentation and timelines will strengthen your case as the lawsuit unfolds.

For comprehensive support and guidance, reach out to Levi & Korsinsky to secure your interests as this significant class action prepares to move forward.